Literature DB >> 22318758

Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.

Ilaria Malandrucco1, Patrizio Pasqualetti, Ilaria Giordani, Dario Manfellotto, Federica De Marco, Filippo Alegiani, Anna Maria Sidoti, Fabiana Picconi, Alessandra Di Flaviani, Gaetano Frajese, Riccardo C Bonadonna, Simona Frontoni.   

Abstract

BACKGROUND: Caloric restriction in obese diabetic patients quickly improves glucose control, independently from weight loss. However, the early effects of a very-low-calorie diet (VLCD) on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes are still unclear.
OBJECTIVE: The objective was to study the relative contributions of insulin sensitivity, insulin secretion, or both to improvement in glucose metabolism, after 1 wk of caloric restriction, in severely obese diabetic patients.
DESIGN: Hyperglycemic clamps were performed in 14 severely obese (BMI, in kg/m(2): >40) patients with type 2 diabetes in good glucose control (glycated hemoglobin < 7.5%) before and after 7 d of a VLCD (400 kcal/d).
RESULTS: The VLCD caused a 3.22 ± 0.56% weight loss (P < 0.001), 42.0% of which was fat loss, accompanied by decreases in fasting plasma glucose (P < 0.05) and triglycerides (P < 0.01). In parallel, the Disposition Index, which measures the body's capability to dispose of a glucose load, increased from 59.0 ± 6.3 to 75.5 ± 6.3 mL· min(-1) · m(-2) body surface area (P < 0.01), because of improvements in indexes of both first- and second-phase insulin secretion (P < 0.02), but with no changes in insulin sensitivity (P = 0.33).
CONCLUSION: The marked improvement in metabolic profile, observed in severely obese patients with type 2 diabetes after a 7-d VLCD, was primarily due to the amelioration of β cell function, whereas no contribution of insulin sensitivity was shown. This trial was registered at www.clinicaltrials.gov as NCT01447524.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318758     DOI: 10.3945/ajcn.111.023697

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  44 in total

1.  Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue.

Authors:  Cyrus Jahansouz; Federico J Serrot; Brigitte I Frohnert; Rocio E Foncea; Robert B Dorman; Bridget Slusarek; Daniel B Leslie; David A Bernlohr; Sayeed Ikramuddin
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

2.  Weight of the nation: moving forward, reversing the trend using medical care.

Authors:  George L Blackburn
Journal:  Am J Clin Nutr       Date:  2012-10-03       Impact factor: 7.045

3.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

4.  Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

Authors:  Antonella Maffei; Ann Marie Segal; Juan Carlos Alvarez-Perez; Adolfo Garcia-Ocaña; Paul E Harris
Journal:  Mol Endocrinol       Date:  2015-03-09

5.  Reversal of type 2 diabetes in youth who adhere to a very-low-energy diet: a pilot study.

Authors:  Megan L Gow; Louise A Baur; Nathan A Johnson; Chris T Cowell; Sarah P Garnett
Journal:  Diabetologia       Date:  2016-11-26       Impact factor: 10.122

6.  Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.

Authors:  Laurentiu M Pop; Andrea Mari; Tong-Jin Zhao; Lori Mitchell; Shawn Burgess; Xilong Li; Beverley Adams-Huet; Ildiko Lingvay
Journal:  Diabetes Obes Metab       Date:  2018-04-10       Impact factor: 6.577

Review 7.  Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  J Sonya Haw; Karla I Galaviz; Audrey N Straus; Alysse J Kowalski; Matthew J Magee; Mary Beth Weber; Jingkai Wei; K M Venkat Narayan; Mohammed K Ali
Journal:  JAMA Intern Med       Date:  2017-12-01       Impact factor: 21.873

Review 8.  Calorie restriction and its impact on gut microbial composition and global metabolism.

Authors:  Xiaojiao Zheng; Shouli Wang; Wei Jia
Journal:  Front Med       Date:  2018-11-16       Impact factor: 4.592

9.  Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial.

Authors:  Andrei Keidar; Karen J Hershkop; Limor Marko; Chaya Schweiger; Lior Hecht; Noam Bartov; Assaf Kedar; Ram Weiss
Journal:  Diabetologia       Date:  2013-06-14       Impact factor: 10.122

10.  Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes.

Authors:  Matheni Sathananthan; Meera Shah; Kim L Edens; Karen B Grothe; Francesca Piccinini; Luca P Farrugia; Francesco Micheletto; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Michael Camilleri; Adrian Vella
Journal:  J Nutr       Date:  2015-08-05       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.